ORBIMED ADVISORS LLC

Position in DHR — Danaher Corp /De/

CIK 1055951 New York, NY

Position in DHR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$50,395,680

-$18,234,536 QoQ

Shares Held

265,800

-11.3% QoQ

Ownership

0.038%

of shares outstanding

% of Portfolio

1.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

ORBIMED ADVISORS LLC holds $728,348,629 across 5 Diagnostics & Research names. DHR ranks #3 (6.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MYGN	Myriad Genetics Inc	125,000,000	$562,500,000
2	NTRA	Natera, Inc.	262,000	$52,397,380
3	DHR	Danaher Corp /De/ This page	265,800	$50,395,680
4	GH	Guardant Health, Inc.	435,200	$40,199,424
5	TMO	Thermo Fisher Scientific Inc.	46,500	$22,856,145

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$50,395,680	265,800	-11.3%	Shares	Sole	2026-05-15
2025-12-31	$68,630,216	299,800	+13.9%	Shares	Sole	2026-02-17
2025-09-30	$52,162,206	263,100	—	Shares	Sole	2025-11-14
No filing history on record for this holder in this stock.